Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports. Actionable insights into research performance. Detailed analysis of strengths and ...
Jackson Laboratory entered a five-year research deal with multinational pharmaceutical company GSK to study Alzheimer’s disease using stem cells. The collaboration aims to develop stem cell-based ...
(Bar Harbor, Maine and Farmington Conn. – Sept. 27, 2024) – In celebration of World Heart Day on Sept. 29,The Jackson Laboratory’s Clinical Education team proudly announces the completion of a novel ...
The Department of Health and Human Services is tapping the Jackson Laboratory to expand testing using lab-grown cells and artificial intelligence, following the lab's acquisition of the New York Stem ...
Developing new drugs is one of the riskiest and most expensive endeavors in science. Today, The Jackson Laboratory (JAX) announced a bold initiative to improve that trajectory, powered by an up to $30 ...
BAR HARBOR, Maine, Dec. 8, 2025 /PRNewswire/ -- Developing new drugs is one of the riskiest and most expensive endeavors in science. Today, The Jackson Laboratory (JAX) announced a bold initiative to ...
Lon Cardon, a pioneer in human genetics and drug discovery, will succeed current President and CEO Dr. Edison Liu in late November. UMaine grad Ryan Tewhey, a human genetics researcher, took his dream ...
Pharma giant GSK is launching a five-year collaboration with The Jackson Laboratory–New York Stem Cell Foundation Collaborative (JAX-NYSCF) to advance human cellular models of neurodegenerative ...
The Jackson Laboratory has disclosed short transient receptor potential channel 3 (TRPC3) and short transient receptor potential channel 6 (TRPC6) antagonists reported to be useful for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results